Trial Profile

A Phase 2 clinical trial for once daily oral testosterone undecanoate for the treatment of male hypogonadism.

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 22 May 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Testosterone undecanoate (Primary)
Indications Hypogonadism
Focus Therapeutic Use
Sponsors Clarus Therapeutics

Most Recent Events

22 May 2022 New trial record
16 May 2022 According to a Clarus Therapeutics media release, this trial is expected to be initiated in the second half of 2022, subject to availability of funding

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com